@CNN: A pharmaceutical exec defended his company’s recent 400% drug price increase, telling the Financial Times his company had a “moral requirement to sell the product at the highest price.”
The head of the FDA blasted the executive in a response on Twitter. https://t.co/j0C6AvLog4 https://t.co/ELH9w5jdK6
A pharmaceutical exec defended his company's recent 400% drug price increase, telling the Financial Times his company had a "moral requirement to sell the product at the highest price."
The head of the FDA blasted the executive in a response on Twitter. https://t.co/j0C6AvLog4 pic.twitter.com/ELH9w5jdK6
— CNN (@CNN) September 12, 2018